MN/CA IX is a cell surface protein, strongly associated with several types of human carcinomas. It exerts activity of carbonic anhydrase and capacity of binding to cell surface receptors. In the present work, we used affinity purified MN/CA IX protein to demonstrate that the cells adhere to immobilized MN/CA IX and that the monoclonal antibody M75 abrogates cell attachment to MN/CA IX. Using synthetic oligopeptides, we identified M75 epitope and located it in the proteoglycan domain, which contains a sixfold tandem repeat of six amino acids GEEDLP. From phage display library of random heptapeptides we identified and chemically synthesized those which compete for the epitope with M75 and inhibit adhesion of cells to MN/CA IX. These heptapeptides might serve as lead compounds for drug design.

Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague

Zobrazit více v PubMed

Int J Cancer. 1993 May 8;54(2):268-74 PubMed

Am J Pathol. 1998 Jul;153(1):279-85 PubMed

Hum Pathol. 1997 Jun;28(6):740-4 PubMed

Proc Natl Acad Sci U S A. 1984 Oct;81(19):5985-8 PubMed

FEBS Lett. 1972 Aug 1;24(2):229-235 PubMed

Virology. 1992 Apr;187(2):620-6 PubMed

J Clin Oncol. 1997 Apr;15(4):1529-37 PubMed

Int J Cancer. 1986 Oct 15;38(4):489-94 PubMed

Cancer Res. 1997 Jul 15;57(14):2827-31 PubMed

Eur Respir J. 1999 Oct;14(4):806-11 PubMed

Am J Pathol. 1994 Sep;145(3):598-609 PubMed

Oncogene. 1994 Oct;9(10):2877-88 PubMed

Genomics. 1996 May 1;33(3):480-7 PubMed

J Histochem Cytochem. 1998 Apr;46(4):497-504 PubMed

Impairment of carbonic anhydrase IX ectodomain cleavage reinforces tumorigenic and metastatic phenotype of cancer cells

Antibody-pHPMA functionalised fluorescent silica nanoparticles for colorectal carcinoma targeting

DNA-linked Inhibitor Antibody Assay (DIANA) for sensitive and selective enzyme detection and inhibitor screening

Apoptosis-induced ectodomain shedding of hypoxia-regulated carbonic anhydrase IX from tumor cells: a double-edged response to chemotherapy

Feasibility and constraints of particle targeting using the antigen-antibody interaction

Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients